Widthness LLC

Advanced Technology and Business Portal – Intel Xeon and A.I. Powered

US regulators approve two gene therapies for sickle cell disease

1 min read
US regulators approve two gene therapies for sickle cell disease US regulators approve two gene therapies for sickle cell disease
Advertisements

Image caption: A blood cell altered by sickle cell disease. Image credit: AP. Article by Edward Helmore. The Guardian – December 8, 2023.

The US Food and Drug Administration has approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough Crispr gene-editing technology, opening up two “transformative therapy” avenues for some patients. The FDA […]

Advertisements
author avatar
Curated by Theresa Wysocki
The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.